We are live on
!
Find out more
BCM
BlueCrest Capital Management Portfolio holdings
AUM
$1.69B
1-Year Est. Return
20.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.31%
1 Year Est. Return
+20.01%
3 Year Est. Return
+41.66%
5 Year Est. Return
+41.11%
10 Year Est. Return
+377.48%
AUM
$2.58B
AUM Growth
+$469M
(+22%)
Cap. Flow
+$242M
Cap. Flow
% of AUM
9.38%
Top 10 Holdings %
Top 10 Hldgs %
13%
Holding
1,235
New
516
Increased
187
Reduced
143
Closed
352
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$43.8M |
| 2 |
ExxonMobil
XOM
|
+$27.8M |
| 3 |
Stanley Black & Decker
SWK
|
+$20.7M |
| 4 |
RSPP
RSP Permian, Inc.
RSPP
|
+$20.7M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$18.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edison International
EIX
|
+$30.5M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$26.3M |
| 3 |
Comcast
CMCSA
|
+$26.1M |
| 4 |
Visa
V
|
+$24.1M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$23.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.26% |
| 2 | Industrials | 12.81% |
| 3 | Energy | 12.4% |
| 4 | Consumer Discretionary | 7.22% |
| 5 | Materials | 5.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Ionis Pharmaceuticals
IONS
$9.14B
| $1.41M | 0.05% |
27,706
+16,215
| +141% | +$755K |
|
377
Mondelez International
MDLZ
$80.2B
| $1.4M | 0.05% |
+32,494
| New | +$1.47M |
|
378
CALL
Trinity Industries
TRN
$3.03B
| $1.4M | 0.05% |
+69,450
| New | +$1.33M |
|
|
HOME
379
DELISTED
At Home Group Inc.
HOME
| $1.4M | 0.05% |
+60,155
| New | +$1.14M |
|
380
Devon Energy
DVN
$49.2B
| $1.4M | 0.05% |
+43,712
| New | +$1.6M |
|
381
Murphy USA
MUSA
$11.1B
| $1.39M | 0.05% |
18,712
+15,280
| +445% | +$1.07M |
|
382
CSX Corp
CSX
$94.2B
| $1.36M | 0.05% |
74,823
-65,187
| -47% | -$1.12M |
|
|
DNKN
383
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $1.35M | 0.05% |
+24,464
| New | +$1.37M |
|
384
Edwards Lifesciences
EW
$48.2B
| $1.34M | 0.05% |
34,137
-140,415
| -80% | -$5.13M |
|
385
Herbalife
HLF
$1.3B
| $1.34M | 0.05% |
37,720
+30,806
| +446% | +$1.04M |
|
386
Merck
MRK
$326B
| $1.32M | 0.05% |
+21,601
| New | +$1.31M |
|
387
Avery Dennison
AVY
$12.9B
| $1.32M | 0.05% |
+14,903
| New | +$1.25M |
|
388
Genpact
G
$5.87B
| $1.31M | 0.05% |
+47,265
| New | +$1.23M |
|
|
GOV
389
DELISTED
Government Properties Income Trust
GOV
| $1.31M | 0.05% |
+71,644
| New | +$1.56M |
|
390
Alnylam Pharmaceuticals
ALNY
$38.5B
| $1.3M | 0.05% |
+16,347
| New | +$1.04M |
|
|
SRCI
391
DELISTED
SRC Energy Inc
SRCI
| $1.3M | 0.05% |
+193,275
| New | +$1.42M |
|
392
WEC Energy
WEC
$37B
| $1.29M | 0.05% |
+20,983
| New | +$1.3M |
|
393
Carlisle Companies
CSL
$14.1B
| $1.28M | 0.05% |
+13,391
| New | +$1.35M |
|
394
Pfizer
PFE
$144B
| $1.28M | 0.05% |
40,096
-132,974
| -77% | -$4.19M |
|
|
PR
395
Permian Resources
PR
$16.5B
| $1.27M | 0.05% |
80,424
+33,222
| +70% | +$546K |
|
|
HBI
396
DELISTED
Hanesbrands
HBI
| $1.26M | 0.05% |
+54,459
| New | +$1.17M |
|
|
BNY
397
Bank of New York Mellon
BNY
$106B
| $1.26M | 0.05% |
+24,675
| New | +$1.18M |
|
398
Granite Construction
GVA
$5.31B
| $1.26M | 0.05% |
26,078
-51,108
| -66% | -$2.54M |
|
399
AES
AES
$10.6B
| $1.25M | 0.05% |
112,652
-3,155
| -3% | -$36.2K |
|
|
WCC
400
WESCO International
WCC
$16.1B
| $1.25M | 0.05% |
21,807
-38,419
| -64% | -$2.38M |
|
Similar funds
ISS
SGI
AAM
PP
RSCM
ACM
GAM
FACM
BlueCrest Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, BlueCrest Capital Management held 1,235 positions worth $2.58B, up 22% from $2.11B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BlueCrest Capital Management deployed $242M of net new capital in Q2 2017, opening 516 new positions and adding to 187 existing holdings. Its largest new stake was ExxonMobil: 340,091 shares worth $27.5M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Industrials and Energy.
On the sell side, the largest reduction was Edison International, an estimated $30.5M trimmed.
- BlueCrest Capital Management's largest Q2 2017 buy was ExxonMobil: 340,091 shares worth $27.5M.
- BlueCrest Capital Management added most to State Street Technology Select Sector SPDR ETF in Q2 2017, an estimated $43.8M increase.
- BlueCrest Capital Management's biggest Q2 2017 reduction was Edison International, cutting an estimated $30.5M.
- BlueCrest Capital Management fully exited Comcast in Q2 2017, selling an estimated $26.1M.
- BlueCrest Capital Management's ten largest holdings make up 13% of its $2.58B portfolio in Q2 2017.
- BlueCrest Capital Management opened 516 new positions and closed 352 in Q2 2017.
- BlueCrest Capital Management's portfolio value rose 22% quarter-over-quarter to $2.58B.
Based on BlueCrest Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.